Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
about
Diet Versus Exercise in Weight Loss and Maintenance: Focus on TryptophanPathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewTryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in HumansThe Neurobiology of Bipolar Disorder: An Integrated ApproachComorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological MechanismsDisturbed tryptophan metabolism in cardiovascular diseaseNeuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?Distinct plasma immune signatures in ME/CFS are present early in the course of illnessInflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis.Molecular Targets of Cannabidiol in Neurological DisordersTryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.(13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder.Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.Increased Neutrophil/Lymphocyte Ratio in Patients with Depression is Correlated with the Severity of Depression and Cardiovascular Risk FactorsAlterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats.Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Does CRP predict outcome in bipolar disorder in regular outpatient care?Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia.Tryptophan hydroxylase 2 in seasonal affective disorder: underestimated perspectives?Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Biological hypotheses and biomarkers of bipolar disorder.A non-targeted metabolite profiling pilot study suggests that tryptophan and lipid metabolisms are linked with ADHD-like behaviours in dogs.Cross Talk: The Microbiota and Neurodevelopmental Disorders.Recurrence of Panic Attacks after Influenza Vaccination: Two Case ReportsThe role of tryptophan metabolism in postpartum depression.An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring.Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.The G allele in IL-10-1082 G/A may have a role in lowering the susceptibility to panic disorder in female patients.Kynurenine pathway and white matter microstructure in bipolar disorder.Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?Early-life adversity-induced long-term epigenetic programming associated with early onset of chronic physical aggression: Studies in humans and animals.Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.Mitochondrial Agents for Bipolar Disorder.Overexpression of indoleamine 2, 3-dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway.Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder.
P2860
Q26747588-01FD52EA-F0FB-4032-9ED4-E837C9E4F39AQ26749017-380937BB-8E16-4D46-8CE4-208D3EEB74E7Q26765775-AEBD2DC4-CC8C-427E-BB68-7C46610BBD5DQ26766633-94C7E31B-F9EB-48C8-B35C-1E0EE4A1814DQ26784356-0345E3A1-627A-47AE-8AA2-A446BE118F83Q27010486-C84E50EE-3691-4E71-9C69-C386F76A7CB3Q28080344-23FAB146-5DB7-4D08-BC79-F8383D04BAADQ28263550-CD3A1F29-E6D4-4479-A00C-6F1C008CC55EQ35233681-F95C5658-7007-4410-AC4F-6A3D5662A8C9Q36157649-9BDAC87D-715C-48AE-987E-3B70D7B6B7F1Q36189171-8E155771-A317-418C-8DE6-70D61489D8ABQ36241987-E1660667-02A5-43BD-B41E-D7C0819B3EEBQ36256757-3B746E3E-B4B7-48F1-99DE-ED8822273874Q36431103-C512E783-7D66-44C7-877A-DB99603828ABQ36431389-9440351B-155C-4448-A9A1-AB482EAEC820Q37013795-EDC015B4-0CE9-4F4E-83C5-A676C958CF67Q37104437-3A8102BC-90CE-4F6B-B1E7-DFDCCB7EC742Q37686937-3445AF59-CC18-41D4-B58D-54D9F52D8FCBQ38270172-F402DBCE-FEA7-411E-A35A-4FD3BE5578EAQ38545958-604CB8C4-8241-46FA-8087-0FD25B8BB026Q38805367-F2C8D138-B643-4B7A-A4A9-E6B33AF6F24AQ38995726-7AC7C2A9-099E-4A50-BE51-8FAFAC762E20Q41240585-81104FC1-8ABA-4D46-96EB-FD9D15843CF8Q41665354-143F7368-7389-4A68-89C9-8E3ABB04037DQ42379070-DEF87855-A9B6-45EB-82A0-573EDAFC81A6Q47201558-B51434C8-B1F6-49EE-AC7D-72CD45887E78Q47294091-7513F348-9B40-45AE-A934-51EEFC097AF2Q47902256-40968809-6227-4FE6-BD2A-158754B12F6CQ47935886-60BC86E7-267E-46D8-A453-A0D17F84AB45Q47959870-C27A5285-55A9-4E4A-A177-AE9267438AEEQ48041301-59FCB837-9D05-4C23-B104-EC738398665AQ48173300-6DC18B7F-EBC5-474B-B5FF-664B15B8A1AAQ52097446-E1ECA631-D419-43D5-AB4A-F9840F9859F7Q52121093-AC3AB83A-88A5-4614-8443-6ED9186FC9D9Q52621890-C2796CA4-EB64-4ACA-8730-CD401E06856EQ55022569-488EE4BA-595F-40E7-AB55-E6ACCA6C3E60Q55421233-F1A42B50-75CC-4804-AA0C-FECA8BCB025D
P2860
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@ast
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@en
type
label
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@ast
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@en
prefLabel
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@ast
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@en
P1476
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
@en
P2093
Aye-Mu Myint
Yong-Ku Kim
P304
P356
10.1016/J.PNPBP.2013.08.008
P577
2013-10-31T00:00:00Z